Bandurska-Luque Anna, Piotrowski Tomasz, Skrobała Agnieszka, Ryczkowski Adam, Adamska Krystyna, Kaźmierska Joanna
Radiotherapy Department II, Greater Poland Cancer Centre, Poznań, Poland.
Department of Electroradiology, University of Medical Sciences, Poznań, Poland ; Medical Physics Department, Greater Poland Cancer Centre, Poznań, Poland.
Rep Pract Oncol Radiother. 2015 Jan 18;20(2):145-52. doi: 10.1016/j.rpor.2014.12.002. eCollection 2015 Mar-Apr.
This prospective study aims to assess feasibility of helical tomotherapy (HT) for craniospinal irradiation (CSI) and perform dosimetric comparison of treatment plans for both HT and 3D conformal radiotherapy (3DCRT).
CSI is a challenging procedure. Large PTV size requires field matching due to technical limitations of standard linear accelerators, which cannot irradiate such volumes as a single field. HT could help to avoid these limitations as irradiation of long fields is possible without field matching.
Three adults were enrolled from 2009 to 2010. All patients received radiochemotherapy. Treatment plans in prone position for 3DCRT and in supine position for HT were generated. The superior plan was used for patients' irradiation. Plans were compared with the application of DVH, Dx parameters - where x represents a percentage of the structure volume receiving a normalized dose and homogeneity index (HI).
All patients received HT irradiation. The treatment was well tolerated. The HT plans resulted in a better dose coverage and uniformity in the PTV: HI were 5.4, 7.8, 6.8 for HT vs. 10.3, 6.6, 10.4 for 3DCRT. For most organs at risk (OARs), the D(V80) was higher for HT than for 3DCRT, whereas D(V5) was lower for HT.
HT is feasible for CSI, and in comparison with 3DCRT it improves PTV coverage. HT reduces high dose volumes of OARs, but larger volumes of normal tissue receive low radiation dose. HT requires further study to establish correlations between dosimetrical findings and clinical outcomes, especially with regard to late sequelae of treatment.
本前瞻性研究旨在评估螺旋断层放射治疗(HT)用于全脑全脊髓照射(CSI)的可行性,并对HT和三维适形放疗(3DCRT)的治疗计划进行剂量学比较。
CSI是一项具有挑战性的操作。由于标准直线加速器的技术限制,PTV体积较大需要进行野匹配,标准直线加速器无法将如此大的体积作为一个单野进行照射。HT有助于避免这些限制,因为无需野匹配就可以对长野进行照射。
2009年至2010年纳入了三名成年人。所有患者均接受了放化疗。生成了3DCRT俯卧位和HT仰卧位的治疗计划。选择较优的计划用于患者照射。通过应用剂量体积直方图(DVH)、Dx参数(其中x代表接受归一化剂量的结构体积百分比)和均匀性指数(HI)对计划进行比较。
所有患者均接受了HT照射。治疗耐受性良好。HT计划在PTV中产生了更好的剂量覆盖和均匀性:HT的HI分别为5.4、7.8、6.8,而3DCRT的HI分别为10.3、6.6、10.4。对于大多数危及器官(OARs),HT的D(V80)高于3DCRT,而HT的D(V5)较低。
HT用于CSI是可行的,与3DCRT相比,它改善了PTV覆盖。HT减少了OARs的高剂量体积,但更大体积的正常组织接受了低辐射剂量。HT需要进一步研究以建立剂量学结果与临床结局之间的相关性,尤其是关于治疗的晚期后遗症。